The Amsterdam universities strongly encourage public-private research collaborations that drive innovation forward and have a positive impact on society. IXA is bridging the connection between Amsterdam academic and applied research and third parties. We call on companies, non-profits, governments, health care and educational institutions that are looking to innovate or find a different perspective to their approach to contact us. Our business developers will assist you.
Whether you are interested in sponsoring a research project, setting up a strategic alliance, or accessing laboratory facilities, we can help you engage in successful research partnerships.
Continue reading after the photo.
We are aware that fruitful collaborations require an environment in which open discussion and exchange of information is safeguarded by a framework that respects the interests of all parties involved. Proper arrangements have to be made regarding ownership of research results, as well as rights to exploitation and publication. IXA has extensive experience in handling all legal and financial aspects concerning research collaborations. Our goal is to establish partnerships that offer true added value to all parties involved.
Amsterdam researchers have secured Biotech Booster funding for a total of six projects, that include a promising cancer treatment, a new diagnostic method for Alzheimer’s Disease, an implant helping blindness, lab innovation in biotechnology, and a nutritional intervention for mental health. The researchers will develop a solid business case for their innovations in the time […]
NewsPULSE Sport, a start-up from the Demonstrator Lab, has reached a significant milestone by winning the prestigious 14th Dutch Sports Innovation Award. The company’s flagship product, a cutting-edge athlete management system, integrates advanced software and artificial intelligence to revolutionize athlete health and performance monitoring. About the Innovation PULSE Sport’s athlete management system provides a holistic […]
NewsVU-AMS is on a mission to revolutionize how we understand and manage stress-related health issues. Now an official VU spin-off, there are big plans for clinical applications. Founder of VU AMS Martin Gevonden explains: “We offer researchers autonomic biomarkers that are valid, reliable and easy to use, without getting under the skin.” After thriving in […]
News